AcuSurgical, operating under the slogan "Creating the new standard of care in retinal surgery", is a promising player in the Health Care and Medical Devices industries. Established in 2020 in Montpellier, France, this innovative startup is pioneering advanced robotic solutions for vitreoretinal procedures. Its mission is to equip surgeons with exceptional tools that enhance precision and improve outcomes in complex ophthalmic surgeries.
The company identified significant limitations within traditional surgical techniques for retinal procedures and is addressing them by integrating robotics into ophthalmology. AcuSurgical is dedicated to developing robotic systems that offer greater control and stability, crucial for operations demanding high precision, such as repairing retinal detachments or treating macular diseases.
With their vision and technological promise, AcuSurgical attracted a €5.75M Series A investment on 18 February 2021, backed by renowned investors including Mérieux Equity Partners, Sofimac Innovation, Supernova Invest, and IRDI. This financial backing sets a strong foundation for further innovation and growth in the field of ophthalmic surgery.